Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Payers Set To Play Hardball On PCSK9 Pricing
Payers Set To Play Hardball On PCSK9 Pricing
Payers Set To Play Hardball On PCSK9 Pricing
Submitted by
admin
on August 14, 2015 - 11:22am
Source:
Investors.com
News Tags:
payer negotiation
drug pricing
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
hepatitis C
Express Scripts
Headline:
Payers Set To Play Hardball On PCSK9 Pricing
Do Not Allow Advertisers to Use My Personal information
